Sensei Biotherapeutics Files 8-K on Financials
Ticker: SNSE · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k, operations
TL;DR
Sensei Biotherapeutics dropped an 8-K detailing its financial condition and results of operations as of March 28, 2025.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on March 28, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This filing provides crucial updates on Sensei Biotherapeutics' financial health and operational performance, which are key indicators for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediate negative news or significant changes.
Key Numbers
- 001-39980 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-1863385 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- March 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Rockville, MD (location) — Address of Principal Executive Offices
- Boston, MA (location) — Former Address of Principal Executive Offices
FAQ
What specific financial information is detailed in the 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated March 28, 2025.
Where are Sensei Biotherapeutics' principal executive offices located?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What was Sensei Biotherapeutics' former address?
The former address of principal executive offices was 451 D Street, Suite 710, Boston, MA 02210.
What is the company's standard industrial classification?
The company's Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).